Using the Lymph Fistula Rat Model to Study Incretin Secretion

Vitamins and Hormones

Volumn 84, Issue C, 2010, Pages 221-249

  Yoder, Stephanie M ^a   Kindel, Tammy L ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Glucagon like peptide 1 (GLP 1); Glucose dependent insulinotropic polypeptide (GIP); Incretin; Lymph; Lymph fistula rat model

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1;

ANIMAL; ANIMAL MODEL; BOOK; GASTROINTESTINAL TRACT; INTESTINE FISTULA; LYMPHATIC SYSTEM; PATHOPHYSIOLOGY; RAT; SECRETION;

ANIMALS; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; INTESTINAL FISTULA; LYMPHATIC SYSTEM; MODELS, ANIMAL; RATS;

EID: 78649392023     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381517-0.00008-4     Document Type: Book

References (95)

1. Adrian T.E., Bloom S.R., Edwards A.V. Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves. J. Physiol. 1983, 344:25-35.
2. Amato A., Cinci L., Rotondo A., Serio R., Faussone-Pellegrini M.S., Vannucchi M.G. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. Neurogastroenterol. Motil. 2010, 22:664. e203.
3. Anini Y., Brubaker P.L. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 2003, 52:252-259.
4. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
5. Bayliss W.M., Starling E.H. On the causation of the so-called 'peripheral reflex secretion' of the pancreas. Proc. R. Soc. Lond. B. Biol. 1902, 69:352-353.
6. Besterman H.S., Cook G.C., Sarson D.L., Christofides N.D., Bryant M.G., Gregor M., Bloom S.R. Gut hormones in tropical malabsorption. Br. Med. J. 1979, 2:1252-1255.
7. Beysen C., Karpe F., Fielding B.A., Clark A., Levy J.C., Frayn K.N. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 2002, 45:1533-1541.
8. Bollman J.L. A cage which limits the activity of rats. J. Lab. Clin. Med. 1948, 33:1348.
9. Bollman J.L., Cain M.D., Grindlay J.H. Techniques for the collection of lymph from the liver, small intestine, or thoracic duct of the rat. J. Lab. Clin. Med. 1948, 33:1349-1352.
10. Brown J.C., Mutt V., Pederson R.A. Further purification of a polypeptide demonstrating enterogastrone activity. J. Physiol. 1970, 209:57-64.
11. Cueni L.N., Detmar M. The lymphatic system in health and disease. Lymphat. Res. Biol. 2008, 6:109-122.
12. D'Alessio D., Lu W., Sun W., Zheng S., Yang Q., Seeley R., Woods S.C., Tso P. Fasting and postprandial concentrations of glucagon-like peptide 1 in intestinal lymph and portal plasma: Evidence for selective release of GLP-1 in the lymph system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2163-R2169.
13. Dahan A., Mendelman A., Amsili S., Ezov N., Hoffman A. The effect of general anesthesia on the intestinal lymphatic transport of lipophilic drugs: Comparison between anesthetized and freely moving conscious rat models. Eur. J. Pharm. Sci. 2007, 32:367-374.
14. Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regul. Pept. 2005, 128:117-124.
15. Deacon C.F., Pridal L., Klarskov L., Olesen M., Holst J.J. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am. J. Physiol. Endocrinol. Metab. 1996, 34:E458-E464.
16. Deacon C.F., Nauck M.A., Meier J., Hücking K., Holst J.J. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetes subjects as revealed using a new assay for the intact peptide. J. Clin. Endocrinol. Metab. 2000, 85:3575-3581.
17. Doemling D.B., Steggerda F.R. Chronic thoracic duct-venous shunt preparation in dogs. J. Appl. Physiol. 1960, 15:745-746.
18. Doyle M.E., Egan J.E. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol. Ther. 2007, 113:546-593.
19. Edwards G.A., Porter C.J.H., Caliph S.M., Khoo S., Charman W.N. Animal models for the study of intestinal lymphatic drug transport. Adv. Drug Deliv. Rev. 2001, 50:45-60.
20. Elrick H., Stimmler L., Hlad C.J., Arai Y. Plasma insulin responses to oral and intravenous glucose administration. J. Clin. Endocrinol. Metab. 1964, 24:1076-1082.
21. Eng J., Kleinman W.A., Singh L., Singh G., Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 1992, 267:7402-7405.
22. Fehmann H., Göke R., Göke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr. Rev. 1995, 16:390-410.
23. Frid A.H., Nilsson M., Holst J.J., Björck M.E. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am. J. Clin. Nutr. 2005, 82:69-75.
24. Fukase N., Takahashi H., Manaka H., Igarashi M., Yamatani K., Daimon M., Sugiyama K., Tominaga M., Sasaki H. Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion. Diabetes Res. Clin. Pract. 1992, 15:187-195.
25. Fushiki T., Kojima A., Imoto T., Inoue K., Sugimoto E. An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats. J. Nutr. 1992, 122:2367-2373.
26. Getty-Kaushik L., Song D.H., Boylan M.O., Corkey B.E., Wolfe M.M. Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity 2006, 14:1124-1131.
27. Girardet R.E., Benninghoff D.L. Surgical techniques for long-term study of thoracic duct lymph circulation in dogs. J. Surg. Res. 1973, 15:168-175.
28. Giroix M.H., Vesco L., Portha B. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 1993, 132:815-822.
29. Granger D.N., Barrowman J.A., Kvietys P.R. Clinical Gastrointestinal Physiology 1985, 141-205. W. B. Saunders Co., Philadelphia.
30. Grindlay J.H., Cain J.C., Bollman J.L., Mann F.C. Lymph fistulas in trained dogs; an experimental technique. Surgery 1950, 27:152-158.
31. Gunnarsson P.T., Winzell M.S., Deacon C.F., Larsen M.O., Jelic K., Carr R.D., Ahrén B. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 2006, 147:3173-3180.
32. Gutzwiller J.P., Göke B., Drewe J., Hildebrand P., Ketterer S., Handschin D., Winterhalder R., Conen D., Beglinger C. Glucagon-like peptide-1: A potent regulator of food intake in humans. Gut 1999, 44:81-86.
33. Hansen L., Deacon C.F., Ørskov C., Holst J.J. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 1999, 140:5356-5363.
34. Hansotia T., Drucker D.J. GIP and GLP-1 as incretin hormones: Lessons from single and double incretin receptor knockout mice. Regul. Pept. 2005, 128:125-134.
35. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 2005, 11:90-94.
36. Jang H., Kokrashvili Z., Theodorakis M.J., Carlson O.D., Kim B., Zhou J., Kim H.H., Xu X., Chan S.L., Juhaszova M., Bernier M., Mosinger B., et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15069-15074.
37. Jensen L.T., Olesen H.P., Risteli J., Lorenzen I. External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph. Lab. Anim. Sci. 1990, 40:620-624.
38. Junqueira L.C., Carneiro J. Basic Histology 2005, 281-316. McGraw-Hill Co., New York. 11th ed.
39. Karamanlis A., Chaikomin R., Doran S., Bellon M., Bartholomeusz F.D., Wishart J.M., Jones K.L., Horowitz M., Rayner C.K. Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am. J. Clin. Nutr. 2007, 86:1364-1368.
40. Katsuma S., Hirasawa A., Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem. Biophys. Res. Commun. 2005, 329:386-390.
41. Kieffer T.J., Habener J.F. The glucagon-like peptides. Endocr. Rev. 1999, 20:876-913.
42. Kim S.J., Winter K., Nian C., Tsuneoka M., Koda Y., McIntosh C.H. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J. Biol. Chem. 2005, 280:22297-22307.
43. Kindel T.L., Yang Q., Yoder S.M., Tso P. Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 296:G168-G174.
44. Larsen P.J., Fledelius C., Knudsen L.B., Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induced lasting and reversible weight loss in both normal and obese rats. Diabetes 2001, 50:2530-2539.
45. Lascelles A.K., Morris B. Surgical techniques for the collection of lymph from unanaesthetized sheep. Q. J. Exp. Physiol. Cogn. Med. Sci. 1961, 46:199-205.
46. Layer P., Peschel S., Schlesinger T., Goebell H. Human pancreatic secretion and intestinal motility: Effects of ileal nutrient perfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 1990, 258:G196-G201.
47. Lo C., Xu M., Yang Q., Zheng S., Carey K.M., Tubb M.R., Davidson W.S., Liu M., Woods S.C., Tso P. Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R43-R50.
48. Lu W.J., Yang Q., Sun W., Woods S.C., D'Alessio D., Tso P. The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G963-G971.
49. Lu W.J., Yang Q., Sun W., Woods S.C., D'Alessio D., Tso P. Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G1130-G1138.
50. Maljaars P.W., Peters H.P., Mela D.J., Masclee A.A. Ileal brake: A sensible food target for appetite control. A review. Physiol. Behav. 2008, 95:271-281.
51. Manolas K.J., Adrian T.E., Dunlop H.M., Bacarese-Hamilton A.J., Bloom S.R., Welbourn R.B. Lymph, pancreatic, and gastrointestinal hormones in response to feeding in the conscious pig. Eur. Surg. Res. 1985, 17:324-332.
52. +-glucose cotransporter 1. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15075-15080.
53. McIntryre N., Holdsworth C.D., Turner D.A. New interpretation of oral glucose tolerance. Lancet 1964, 2:20-21.
54. Meier J.J., Nauck M.A. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab. Res. Rev. 2005, 21:91-117.
55. Mentlein R., Gallwitz B., Schmidt W.E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine, and is responsible for their degradation in human serum. Eur. J. Biochem. 1993, 214:829-835.
56. Miyawaki K., Yamada Y., Ban N., Ihara Y., Tsukiyama K., Zhou H., Fujimoto S., Oku A., Tsuda K., Toyokuni S., Hiai H., Mizunoya W., et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat. Med. 2002, 8:738-742.
57. Moore B., Edie E.S., Abram J.H. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem. J. 1906, 1:28-38.
58. Nakanome C., Akai H., Umezu M., Toyota T., Goto Y. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus. Tohoku J. Exp. Med. 1983, 139:287-292.
59. Näslund E., Barkeling B., King N., Gutniak M., Blundell J.E., Holst J.J., Rössner S., Hellström P.M. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. 1999, 23:304-311.
60. Nauck M.A. Unraveling the science of incretin biology. Am. J. Med. 2009, 122:S3-S10.
61. Nauck M.A., Heimesaat M.M., Ørskov C., Holst J.J., Ebert R., Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 1993, 91:301-307.
62. Nauck M.A., Niedereichholz U., Ettler R., Holst J.J., Ørskov C., Ritzel R., Schmiegel W.H. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am. J. Physiol. Endocrinol. Metab. 1997, 273:E981-E988.
63. Ostenson C.G., Efendic S. Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans. Diabetes Obes. Metab. 2007, 9(Suppl. 2):180-186.
64. Parker H.E., Habib A.M., Rogers G.J., Gribble F.M., Reimann F. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 2009, 52:289-298.
65. Polderman H., McCarrell J.D., Beecher H.K. Effect of anesthesia on lymph flow (local procaine, ether, pentobarbital sodium). Anesthesiology 1944, 5:400-406.
66. Porter C.J.H., Charman W.N. Model systems for intestinal lymphatic transport studies. Models for Assessing Drug Absorption and Metabolism 1996, Vol. 8:85-102. Plenum Press, New York.
67. Rampone A.J. Experimental thoracic duct fistula for conscious dogs. J. Appl. Physiol. 1959, 14:150-152.
68. Reimann F., Gribble F.M. Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 2002, 51:2757-2763.
69. Reimann F., Williams L., da Silva Xavier G., Rutter G.A., Gribble F.M. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 2004, 47:1592-1601.
70. Reimann F., Habib A.M., Tolhurst G., Parker H.E., Rogers G.J., Gribble F.M. Glucose sensing in L cells: A primary cell study. Cell Metab. 2008, 8:532-539.
71. Roberge J.N., Brubaker P.L. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 1993, 133:233-240.
72. Rocca A.S., Brubaker P.L. Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures. Endocrinology 1995, 136:5593-5599.
73. Rocca A.S., Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999, 140:1687-1694.
74. Rocca A.S., LaGreca J., Kalitsky J., Brubaker P.L. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 2001, 142:1148-1155.
75. Romsos D.R., McGilliard A.D. Preparation of thoracic and intestinal lymph duct shunts in calves. J. Dairy Sci. 1970, 53:1275-1278.
76. Schmidt W.E., Siegel S.E., Creutzfeldt W. Glucagon-like peptide-1 but not glucagon-like-peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 1985, 28:704-707.
77. Sherman I.A., Dlugosz J.A., Barker F., Sadeghi F.M., Pang K.S. Dynamics of arterial and portal venous flow interactions in perfused rat liver: An intravital microscopic study. Am. J. Physiol. Gastrointest. Liver Physiol. 1996, 271:G201-G210.
78. Spiller R.C., Trotman I.F., Adrian T.E., Bloom S.R., Misiewicz J.J., Silk D.B. Further characterisation of the 'ileal brake' reflex in man-Effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988, 29:1042-1051.
79. Stepanov B.N. A chronic fistula of the intestinal lymphatic duct of the cat. Biull. Eksp. Biol. Med. 1958, 46:110-113.
80. Swartz M.A. The physiology of the lymphatic system. Adv. Drug Deliv. Rev. 2001, 50:3-20.
81. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., Pellicciari R., Auwerx J., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009, 10:167-177.
82. Thomsen C., Rasmussen O., Lousen T., Holst J.J., Fenselau S., Schrezenmeir J., Hermansen K. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am. J. Clin. Nutr. 1999, 69:1135-1143.
83. Tong J., Tschöp M.H., Aulinger B.A., Davis H.W., Yang Q., Liu J., Gaylinn B.D., Thorner M.O., D'Alessio D., Tso P. The intestinal lymph fistula model-A novel approach to study ghrelin secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G474-G480.
84. Tso P., Simmonds W.J. The absorption of lipid and lipoprotein synthesis. Lipid Research Methodology 1984, Vol. 10:191-216. Alan R. Liss Inc., New York.
85. Tsuchiya M., Ferrone R.A., Walsh G.M., Frohlich E.D. Regional blood flows measured in conscious rats by combined Fick and microsphere methods. Am. J. Physiol. Heart Circ. Physiol. 1978, 235:H357-H360.
86. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M.B., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P.H., Smith D.M., et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379:69-72.
87. Vaag A.A., Holst J.J., Vølund A., Beck-Nielsen H.B. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)-Evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins. Eur. J. Endocrinol. 1996, 135:425-432.
88. Vilsbøll T., Krarup T., Deacon C.F., Madsbad S., Holst J.J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001, 50:609-613.
89. Vilsbøll T., Krarup T., Madsbad S., Holst J.J. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul. Pept. 2003, 114:115-121.
90. Wang Y., Montrose-Rafizadeh C., Adams L., Raygada M., Nadiv O., Egan J.M. GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells. Mol. Cell. Endocrinol. 1996, 116:81-87.
91. Waynforth H.B., Flecknell P.A. Experimental and Surgical Techniques in the Rat 1992, Elsevier Ltd., London. 2nd ed.
92. White D.G., Story M.J., Barnwell S.G. An experimental animal model for studying the effects of a novel lymphatic drug delivery system for propranolol. Int. J. Pharm. 1991, 69:169-174.
93. Wren A.M., Bloom S.R. Gut hormones and appetite control. Endocrinology 2007, 132:2116-2130.
94. Yoder S.M., Yang Q., Kindel T.L., Tso P. Stimulation of incretin secretion by dietary lipid: Is it dose dependent?. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297:G299-G305.
95. Zhou H., Yamada Y., Tsukiyama K., Miyawaki K., Hosokawa M., Nagashima K., Toyoda K., Naitoh R., Mizunoya W., Fushiki T., Kadowaki T., Seino Y. Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action. Biochem. Biophys. Res. Commun. 2005, 335:937-942.